
The latest news and exclusive analysis across the FDA-regulated industries from former FDA professionals and industry experts. Save time gathering the critical industry intelligence you need to act on.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 560 | Founded | 5 years ago | Last Issue | 7 days ago |
| Active | |||||

The FDA just announced the final design of its Expedited Investigational New Drug Pilot and began accepting applications. Applications can be submitted until October 30, after which the FDA says it plans to review and choose participants by...
We recently published our comprehensive guide to annual audit planning and companion checklist for Q3.
To step back and tackle GxP audit planning more generally, we put a question to our account managers who build client audit schedules an...
Subscribe to our podcast, The Life Science Rundown, if you haven’t already.
Regulatory operations professionals tend to get described by their outputs.
Hyperlinks, bookmarks, publishing, the mechanics of getting a dossier out the door cor...
As the FDA takes its first steps toward receiving clinical data in real time, what happens to regulatory operations professionals? Carla Griffin, CEO of The Sugar Water Operations Team, argues that reg ops has been kept in too small a box f...
Watch now (42 mins) | The FDA rewrites how sponsors request meetings during drug development, folds human factors into the quality system, and posts a warning letter written against ISO 13485 clauses in the QMSR.
Welcome to Insider issue #...
Subscribers, engagement, traffic and sponsorship for The FDA Group's Insider Newsletter.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #98 |
The writers behind this newsletter.
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates.
You can find recent issues that have been published by The FDA Group's Insider Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The FDA Group's Insider Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The FDA Group's Insider Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The FDA Group's Insider Newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The FDA Group's Insider Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.